DowDuPont Announces Effectiveness of the Form 10 Registration Statement for New Dow

MIDLAND, Mich. & WILMINGTON, Del. - March 13, 2019 -

\r DowDuPont (NYSE:DWDP) today announced that the U.S. Securities and \r Exchange Commission has declared effective the Registration Statement on \r Form 10 filed by Dow Inc. (“Dow”). The Form 10 includes information \r regarding Dow’s business and strategy as well as details on the \r spin-off, which is expected to be completed on April 1, 2019.\r

\r

\r “Today’s announcement of the Form 10 effectiveness marks the final \r regulatory milestone in our process to spin. Dow is separating as an \r independent, publicly traded company in a position of strength and with \r a clear roadmap to deliver long-term value for our shareholders,” said \r Jim Fitterling, chief operating officer of the Materials Science \r Division of DowDuPont and chief executive officer elect of Dow.\r

\r

\r As previously announced, on March 7, 2019, the DowDuPont board of \r directors approved the spin-off of DowDuPont’s Materials Science \r Division and declared a pro rata dividend of Dow’s common stock. The \r dividend is expected to be paid after the close of business on April 1, \r 2019 to DowDuPont stockholders of record as of the close of business on \r March 21, 2019, the record date. DowDuPont stockholders will receive one \r share of Dow common stock for every three shares of DowDuPont common \r stock they held on the record date, plus cash in lieu of any fractional \r shares.\r

\r

\r The New York Stock Exchange has authorized Dow’s common stock for \r listing and has advised that “when-issued” trading in Dow common stock \r on the NYSE will begin on March 20, 2019, under the symbol “DOW WI”. \r Following the spin-off, on April 2, 2019, Dow common stock will begin \r “regular way” trading on the NYSE under the symbol “DOW” and DowDuPont \r will continue trading under “DWDP”.\r

\r

\r Beginning on March 20, 2019 and continuing through April 1, 2019, it is \r expected that there will be two markets in DowDuPont common stock on the \r NYSE: a “regular-way” market under the symbol “DWDP,” in which DowDuPont \r shares will trade with the right to receive shares of Dow common stock \r in the spin-off, and an “ex distribution market” under the symbol “DWDP \r WI” in which DowDuPont shares will trade without the right to receive \r shares of Dow common stock in the spin-off. If you sell your shares in \r the “regular-way” market on or prior to the distribution date, you \r will be selling your right to receive Dow common stock in the \r distribution.\r

\r

\r The distribution of Dow common stock is subject to the satisfaction or \r waiver of certain customary conditions, which DowDuPont expects will be \r satisfied by the distribution date.\r

\r

\r About DowDuPont™\r

\r

\r DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow \r Chemical Company and DuPont with the intent to form strong, independent, \r publicly traded companies in agriculture, materials science and \r specialty products sectors that will lead their respective industries \r through productive, science-based innovation to meet the needs of \r customers and help solve global challenges. For more information, please \r visit us at www.dow-dupont.com.\r

\r

\r About Dow\r

\r

\r Dow combines science and technology knowledge to develop premier \r materials science solutions that are essential to human progress. Dow \r has one of the strongest and broadest toolkits in the industry, with \r robust technology, asset integration, scale and competitive capabilities \r that enable it to address complex global issues. Dow’s market-driven, \r industry-leading portfolio of advanced materials, industrial \r intermediates and plastics businesses deliver a broad range of \r differentiated technology-based products and solutions for customers in \r high-growth markets such as packaging, infrastructure and consumer care. \r Dow is a subsidiary of DowDuPont (NYSE: DWDP), a holding company \r comprised of Dow and DuPont with the intent to form three strong, \r independent, publicly traded companies in agriculture, materials science \r and specialty sectors. More information can be found at www.dow.com.\r

\r

\r Cautionary Statement About Forward-Looking Statements:\r

\r

\r This communication contains “forward-looking statements” within the \r meaning of the federal securities laws, including Section 27A of the \r Securities Act of 1933, as amended, and Section 21E of the Securities \r Exchange Act of 1934, as amended. In this context, forward-looking \r statements often address expected future business and financial \r performance and financial condition, and often contain words such as \r “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” \r “will,” “would,” “target,” and similar expressions and variations or \r negatives of these words.\r

\r

\r DowDuPont plans to separate into three, independent, publicly traded \r companies—one for each of its agriculture, materials science and \r specialty products businesses (the “Intended Business Separations” and \r the transactions to accomplish the Intended Business Separations, the \r “separations”).\r

\r

\r In furtherance of the Intended Business Separations, DowDuPont is \r engaged in a series of reorganization and realignment steps to realign \r its businesses so that the assets and liabilities aligned with the \r materials science business will be held by legal entities that will \r ultimately be subsidiaries of Dow Inc. (“Dow”) and the assets and \r liabilities aligned with the agriculture business will be held by legal \r entities that will ultimately be subsidiaries of Corteva Inc. \r (“Corteva”). Following this realignment, DowDuPont expects to distribute \r its materials science and agriculture businesses through two separate \r U.S. federal tax-free spin-offs in which DowDuPont stockholders, at the \r time of such spin-offs, will receive pro rata dividends of the shares of \r the capital stock of Dow and of Corteva, as applicable (the \r “distributions”).\r

\r

\r Forward-looking statements by their nature address matters that are, to \r varying degrees, uncertain, including statements about the Intended \r Business Separations, the separations and distributions. Forward-looking \r statements, including those related to the DowDuPont’s ability to \r complete, or to make any filing or take any other action required to be \r taken to complete, the separations and distributions, are not guarantees \r of future results and are subject to risks, uncertainties and \r assumptions that could cause actual results to differ materially from \r those expressed in any forward-looking statements. Forward-looking \r statements also involve risks and uncertainties, many of which are \r beyond the DowDuPont’s control. Some of the important factors that could \r cause DowDuPont’s actual results (including DowDuPont’s agriculture \r business, materials science business or specialty products business) to \r differ materially from those projected in any such forward-looking \r statements include, but are not limited to: (i) ability and costs to \r achieve all the expected benefits, including anticipated cost and growth \r synergies, from the integration of The Dow Chemical Company and E. I. du \r Pont de Nemours and Company and the Intended Business Separations; (ii) \r the incurrence of significant costs in connection with the integration \r of The Dow Chemical Company and E. I. du Pont de Nemours and Company and \r the Intended Business Separations; (iii) risks outside the control of \r DowDuPont, which could impact the decision of the DowDuPont Board of \r Directors to proceed with the Intended Business Separations, including, \r among others, global economic conditions, instability in credit markets, \r declining consumer and business confidence, fluctuating commodity prices \r and interest rates, volatile foreign currency exchange rates, tax \r considerations, and other challenges that could affect the global \r economy, specific market conditions in one or more of the industries of \r the businesses proposed to be separated, and changes in the regulatory \r or legal environment and the requirement to redeem $12.7 billion of \r DowDuPont notes if the Intended Business Separations are abandoned or \r delayed beyond May 1, 2020; (iv) potential liability arising from \r fraudulent conveyance and similar laws in connection with the \r separations and distributions; (v) disruptions or business uncertainty, \r including from the Intended Business Separations, could adversely impact \r DowDuPont’s business, or financial performance and its ability to retain \r and hire key personnel; (vi) uncertainty as to the long-term value of \r DowDuPont common stock; (vii) potential inability to access the capital \r markets; and (viii) risks to DowDuPont’s business, operations and \r results of operations from: the availability of and fluctuations in the \r cost of feedstocks and energy; balance of supply and demand and the \r impact of balance on prices; failure to develop and market new products \r and optimally manage product life cycles; ability, cost and impact on \r business operations, including the supply chain, of responding to \r changes in market acceptance, rules, regulations and policies and \r failure to respond to such changes; outcome of significant litigation, \r environmental matters and other commitments and contingencies; failure \r to appropriately manage process safety and product stewardship issues; \r global economic and capital market conditions, including the continued \r availability of capital and financing, as well as inflation, interest \r and currency exchange rates; changes in political conditions, including \r trade disputes and retaliatory actions; business or supply disruptions; \r security threats, such as acts of sabotage, terrorism or war, natural \r disasters and weather events and patterns which could result in a \r significant operational event for the DowDuPont, adversely impact demand \r or production; ability to discover, develop and protect new technologies \r and to protect and enforce the DowDuPont’s intellectual property rights; \r failure to effectively manage acquisitions, divestitures, alliances, \r joint ventures and other portfolio changes; unpredictability and \r severity of catastrophic events, including, but not limited to, acts of \r terrorism or outbreak of war or hostilities, as well as management’s \r response to any of the aforementioned factors. These risks are and will \r be more fully discussed in DowDuPont’s current, quarterly and annual \r reports and other filings made with the U. S. Securities and Exchange \r Commission (the “Commission”) as well as the registration statement on \r Form 10 of Dow and the preliminary registration statement on Form 10 of \r Corteva, in each case as may be amended from time to time in future \r filings with the Commission. While the list of factors presented here is \r considered representative, no such list should be considered to be a \r complete statement of all potential risks and uncertainties. Unlisted \r factors may present significant additional obstacles to the realization \r of forward-looking statements. Consequences of material differences in \r results as compared with those anticipated in the forward-looking \r statements could include, among other things, business disruption, \r operational problems, financial loss, legal liability to third parties \r and similar risks, any of which could have a material adverse effect on \r DowDuPont’s, Dow’s or Corteva’s consolidated financial condition, \r results of operations, credit rating or liquidity. None of DowDuPont, \r Dow or Corteva assumes any obligation to publicly provide revisions or \r updates to any forward-looking statements whether as a result of new \r information, future developments or otherwise, should circumstances \r change, except as otherwise required by securities and other applicable \r laws. A detailed discussion of some of the significant risks and \r uncertainties which may cause results and events to differ materially \r from such forward-looking statements is included in the section titled \r “Risk Factors” (Part I, Item 1A) of the 2018 annual reports on Form 10-K \r of DowDuPont and as set forth in the preliminary registration statements \r on Form 10 of each of Dow and Corteva, in each case as may be amended \r from time to time in future filings with the Commission.\r

\r

\r Trademarks\r

\r

\r We own or have rights to various trademarks, service marks and trade \r names that we use in connection with the operation of our business. The \r Dow Diamond, DuPont Oval logo, DuPont™, the DowDuPont logo and all \r products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks, \r service marks or registered trademarks of The Dow Chemical Company, E. \r I. du Pont de Nemours and Company, DowDuPont Inc. or their respective \r subsidiaries or affiliates. Solely for convenience, the trademarks, \r service marks and trade names referred to in this communication may \r appear without the ™, ℠ or ® symbols, but such references are not \r intended to indicate, in any way, that we will not assert, to the \r fullest extent under applicable law, our rights or the right of the \r applicable licensor to these trademarks, service marks and trade names. \r This communication may also contain trademarks, service marks and trade \r names of certain third parties, which are the property of their \r respective owners. Our use or display of third parties’ trademarks, \r service marks, trade names or products in this communication is not \r intended to, and should not be read to, imply a relationship with or \r endorsement or sponsorship of us.\r

\r

\r

\r

\r \r \r

For further information, please contact:

DowDuPont

Investors:
Lori Koch
lori.d.koch@dupont.com
+1 302-999-5631

Media:
Dan Turner
daniel.a.turner@dupont.com
+1 302-996-8372

Dow

Investors:
Neal Sheorey
nrsheorey@dow.com
+1 989-636-6347

Media:
Rachelle Schikorra
ryschikorra@dow.com
+1 989-638-4090